AL 2022 Evaluation Form

ESH 3^rd How to Diagnose and Treat
ACUTE LEUKAEMIAS
E-Conference

March 10-13, 2022 – #ESHAL2022

Chairs: Hervé Dombret, Gert Ossenkoppele, Jorge Sierra, Wendy Stock

Step 1 of 4

25%

EVALUATION SHEET

Work Place (Country):(Required)

Years of professional experience:

1-5 Years

5-10 Years

10-20 Years

20 Years and more

Q1: Are you fully trained OR in-training?

Fully Trained: MD

Fully Trained: MD-PhD

Fully Trained: Post Doctoral Researcher

Fully Trained: PhD

Fully Trained: Allied Health Professional

Fully Trained: Corporate

In-training: Resident

In-training: Doctoral Student

In-training: Allied Health Professional

Other:

Q1 Other(Required)

Q2: Your principal activity?

Patient Care

Clinical Research

Other Research

Teaching/Training

Other:

Q2 Other(Required)

Q3: What made you attend this conference?(Required)

Topics

Faculty

Virtual format

Timing

Invitation

Other:

Q3 Other(Required)

Q4: How were you informed of this meeting?(Required)

Electronic mailing

At an ESH conference

At other conferences/congresses

Teaching faculty

Announcement in scientific journals

ESH website

Twitter

Facebook

Other:

Q4 Other(Required)

Please rate the lectures (+2, -1, 0, +1, +2)
-2 = poor | +2 = outstanding

Thursday, March 10^th, 2022

KEYNOTE LECTURE

David Spencer

-2

-1

I didn't attend

SESSION I - DIAGNOSIS AND RARE DISEASES

Elli Papaemmanuil

-2

-1

I didn't attend

Lars Bullinger

-2

-1

I didn't attend

Marielle Wondergem

-2

-1

I didn't attend

Emily Curran

-2

-1

I didn't attend

Wendy Stock

-2

-1

I didn't attend

SESSION II – MESEAURABLE RESIDUAL DISEASE (MRD)

Sylvie Freeman

-2

-1

I didn't attend

Jan Trka

-2

-1

I didn't attend

Adriano Venditti

-2

-1

I didn't attend

Nicolas Boissel

-2

-1

I didn't attend

Farhad Ravandi

-2

-1

I didn't attend

Friday, March 11^th, 2022

SESSION III – LEUKAEMIA TREATMENT DILEMMAS

Lionel Adès

-2

-1

I didn't attend

Paresh Vyas

-2

-1

I didn't attend

Charles Craddock

-2

-1

I didn't attend

David Sallman

-2

-1

I didn't attend

Richard Stone

-2

-1

I didn't attend

DEBATE 1 - INTENSIVE CHEMOTHERAPY FOR OLDER FIT PATIENTS

Christoph Röllig

-2

-1

I didn't attend

Courtney DiNardo

-2

-1

I didn't attend

ROUNDTABLE 1 – MRD LEVEL BEFORE TRANSPLANT

Roland Walter

-2

-1

I didn't attend

Sebastian Giebel

-2

-1

I didn't attend

SIMULTANEOUS MEET THE EXPERT SESSIONS

FLT3inhibition and other targeted treatment – Jordi Esteve, Richard Stone

-2

-1

I didn't attend

Molecular heterogeneity of AML – Lars Bullinger, Elli Papaemmanuil

-2

-1

I didn't attend

Less intensive therapy in AML – Lionel Adès, Gail Roboz

-2

-1

I didn't attend

Saturday, March 12^th, 2022

SESSION IV – LEUKAEMIA TREATMENT CHALLENGES

Eunice Wang

-2

-1

I didn't attend

Alexander Perl

-2

-1

I didn't attend

Gail Roboz

-2

-1

I didn't attend

Jorge Sierra

-2

-1

I didn't attend

Eytan Stein

-2

-1

I didn't attend

ROUNDTABLE 2 – PH-POSITIVE ALL

Yves Chalandon

-2

-1

I didn't attend

Sabina Chiaretti

-2

-1

I didn't attend

Nicholas Short

-2

-1

I didn't attend

DEBATE 2 – CAR-T CELL FOR ALL PARTIENTS

Shannon Maude

-2

-1

I didn't attend

Claire Roddie

-2

-1

I didn't attend

SESSION V – IMMUNE THERAPIES TO TREAT LEUKAEMIA PATIENTS

Hermann Einsele

-2

-1

I didn't attend

Nicola Gökbuget

-2

-1

I didn't attend

Fabio Ciceri

-2

-1

I didn't attend

John DiPersio

-2

-1

I didn't attend

Patrick A. Brown

-2

-1

I didn't attend

SIMULTANEOUS MEET THE EXPERT SESSIONS

Use of asparaginase in adults with ALL – Nicola Gökbuget, Josep Ribera

-2

-1

I didn't attend

Treatment of adolescent and young adults with ALL – Rob Pieters, Wendy Stock

-2

-1

I didn't attend

Treatment of relapsed AML – Charles Craddock, Christian Récher

-2

-1

I didn't attend

Sunday, March 13^th, 2022

SESSION VI – HAEMATOPOIETIC STEM CELL TRANSPLANTATION

Pierre Fenaux

-2

-1

I didn't attend

Rita Assi

-2

-1

I didn't attend

Annoek E. C. Broers

-2

-1

I didn't attend

Robert Zeiser

-2

-1

I didn't attend

Raphaël Itzykson

-2

-1

I didn't attend

PLEASE PROVIDE US WITH YOUR COMMENTS:

Q6: Did this Conference meet your educational expectations?

Yes, absolutely

Yes

Not really

Not at all

Q7: Will you change something in your daily practice as a result of attending this conference?

Yes

Maybe

Q8: Do you consider that this virtual conference provided you with opportunities to ask questions?

Yes

Q9: Did you ask questions?

Yes

Q10: Were your questions answered?

Yes

Q11: Do you consider that this virtual conference provided you with opportunities for scientific interaction and networking?

With faculty members?

With peers?

Q12: What was your preferred session type? (several answers possible):

Plenary Sessions

Meet the Expert sessions

Poster walk

Q13: Did you find the e-platform:

Easy to navigate?

Attractive?

Q14: If ESH holds other virtual haematology conferences in your fields of interest, would you consider registering again?

Yes absolutely

Yes maybe

Probably not

Q15: Did you feel that the presentations at this ESH meeting were evidence-based and objective?

Yes

Q16: If you are a clinician, were they relevant to your clinical practice?

Yes

Q17: How do you evaluate the level of commercial biais at this ESH conference?

Absence of commercial biais

Average Level of commercial biais similar to other conferences organized by major academic institutions in the field

Higher than average level of commercial biais

Please feel free to comment:

CERTIFICATE OF ATTENDANCE

To obtain your Certificate of Attendance please fill the fields below:

First Name:(Required)

Last Name:(Required)

Email Address:(Required)

Verify Email Address:(Required)